Progesterone Receptor-negative Breast Cancer Completed Phase 2 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0028547 (Progesterone Receptor-negative Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00194779Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryTreatment
NCT00577122Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast CancerTreatment